Myst Therapeutics
AcquiredMyst Therapeutics is a biotech company in Los Angeles, United States, founded in 2019.
Novel tumor-infiltrating lymphocyte therapies for solid tumors
- Headquarters
- Los Angeles, California
- Employees
- 1–10
- Founded
- 2019
- Website
- myst-tx.com
- Acquisition Date
- Jan 2021
About
Myst Therapeutics was a privately held biotechnology company focused on developing novel tumor-infiltrating lymphocyte (TIL) T-cell therapies for solid tumors. Founded in 2019 and headquartered in Los Angeles, California, the company built a proprietary TIL technology platform aimed at advancing next-generation cancer immunotherapy. Myst Therapeutics was acquired by Turnstone Biologics Corp. in January 2021, with its TIL technology and programs absorbed into Turnstone's broader cell therapy pipeline targeting solid tumors.
Summary
It lists 1–10 employees.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Jan 2021
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/myst-therapeutics"><img src="https://indexed.vc/api/badge/company/myst-therapeutics" alt="Myst Therapeutics on Indexed.vc" width="260" height="76" /></a>